期刊文献+

诺和锐30和优泌乐25治疗2型糖尿病的初步比较 被引量:5

下载PDF
导出
摘要 目的:探讨每日2次注射诺和锐30和优泌乐25治疗口服降糖药治疗效果不佳的2型糖尿病的疗效及低血糖风险。方法:42例经两种或两种以上口服降糖药治疗后控制不佳的2型糖尿病患者分为诺和锐30组和优泌乐25组。入选病例在继续服用原口服降糖药的基础上,分别采用每日早晚餐前注射诺和锐30和优泌乐25,观察12周。比较12周后两组八点血糖、日均血糖、糖基化血红蛋白(HbA1c)和低血糖发生率。结果:①两组治疗后八点血糖、日均血糖和HbA1c水平均较治疗前明显下降(均P<0.01)。②治疗12周后,诺和锐30组早餐后2h血糖低于优泌乐25组(P<0.05),其他各点血糖、日均血糖和HbA1c水平比较差异无统计学意义(P>0.05)。③诺和锐30组低血糖发生次数与优泌乐25组差异无统计学意义(P>0.05)。结论:对于2型糖尿病患者,每日2次注射诺和锐30较优泌乐25能更好地控制早餐后2h血糖。
作者 黄宾协
出处 《中国医药导报》 CAS 2009年第3期37-38,共2页 China Medical Herald
  • 相关文献

参考文献4

二级参考文献19

  • 1迟志波.胰岛素泵强化治疗新诊断的2型糖尿病临床观察[J].实用糖尿病杂志,2005,1(6):31-32. 被引量:7
  • 2Osterberg O,Erichsen L,Ingwersen SH,et al.Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin[J].J Pharmacokinet Pharmacodyn,2003,30(3):221-235.
  • 3Rakatzi I,Seioke G,Eckel J.[LysB3,GluB29] insulin:a novel insulin analog with enhanced beta-cell protective action[J].J Biochem Biophys Res Commun,2003,310(3):852-859.
  • 4Heinemann L,Linkeschova R,Rave K,et al.Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo[J].Diabetes Care,2000,23(5):644-649.
  • 5Bolli GB,Di Marchi RD,Park GD,et al.Insulin analogues and their potential in the management of diabetes mellitus[J].Diabetologia,1999,42(10):1151-1167.
  • 6Vague P,Selam JL,Skeie S,et al.Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart[J].Diabetes Care,2003,26(3):590-596.
  • 7Hermansen K,Fontaine P,Kukolja KK,et al.Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular insulin) in basal-bolus therapy for patients with type1 diabetes[J].Diabetologia,2004,47(4):622-629.
  • 8KirstineBrownFramdsem.长效胰岛素类似物.国外医学:内分泌学分册,2004,24(4):15-16.
  • 9Vajo Z,Fawcett J,Duckworth WC.Recombinant DNA technology in the treatment of diabetes:insulin analogs[J].Endocr Rev,2001,22 (5):706-717.
  • 10LV Yuan.Insulin analogus-Aspart30[J].Clin Pharmacol,2005,21(3):233-236.

共引文献34

同被引文献125

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部